PCR Perspectives cover art

All Episodes

PCR Perspectives — 48 episodes

#
Title
1

Why is TAVI a different procedure in patient with pure aortic regurgitation?

2

How to manage current challenges of small aortic annulus?

3

In what situation is emergency transcatheter valve intervention a valid alternative to surgery?

4

What are the key considerations for transcatheter mitral paravalvular leak management?

5

What are the key considerations when managing combined mitral and tricuspid regurgitation?

6

How are the 2025 ESC EACTS valvular guidelines going to impact my TAVI programme?

7

Should we consider TTVR in patients with straightforward anatomy who are eligible for T-TEER?

8

Is iatrogenic atrial septum defect closure a necessary procedure?

9

How to manage patients with aortic stenosis and coronary artery disease?

10

How are the 2025 ESC/EACTS valvular guidelines going to impact my mitral programme?

11

What are the key steps in pre procedural assessment for successful LAA closure?

12

The D-PACE scoring system - Can we predict high-grade conduction disturbances after TAVI?

13

How do we meet the needs of women with heart valve disease?

14

What are the key learnings from the 7-year follow-up of PARTNER 3?

15

How are the new 2025 ESC/EACTS valvular guidelines going to impact my tricuspid programme?

16

How to manage the challenges of TAVI in bicuspid disease?

17

What are the essentials of the provisional strategy for non-left main true bifurcation lesions?

18

EuroPCR 2025 Hotline - ACURATE neo2 under-expansion in the ACURATE IDE study: a post-hoc analysis

19

What is the latest in DCB practice?

20

Redo TAVI: how to treat different TAVI platforms when they fail?

21

What are the emerging indications for TAVI in 2025?

22

How will EARLY-TAVI and NOTION-3 impact TAVI practice?

23

Hotline from EuroPCR 2025 - Five-year outcomes from the Evolut low risk TAVR bicuspid study

24

How to manage treatment dilemmas in STEMI patients with multivessel disease?

25

Major EuroPCR 2025 LBT - 4D-ACS: one-month DAPT followed by dose reduction of prasugrel after drug-coated stent insertion in acute coronary syndrome

26

What are the fundamentals of an upfront two-stent strategy for bifurcation PCI?

27

How to tailor transcatheter mitral therapies in 2025? A new era

28

How to successfully approach calcified bifurcation lesions?

29

Major LBTs from EuroPCR 2025 - Meta-Analysis of individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies

30

How to implement the diagnosis of INOCA in everyday practice?

31

How to manage coronary artery disease in TAVI candidates?

32

How to efficiently and safely manage calcified left main disease

33

Vulnerable plaque PCI after PREVENT

34

FAITAVI - Major Late-Breaking Trial from EuroPCR 2025

35

First guidelines for the treatment of LM disease issued by SOLACI and SIAC

36

What are the essential aspects of transcatheter LAA closure?

37

How to successfully approach CTO interventions: a step-by-step approach

38

What is the optimal TAVI access approach in contemporary practice?

39

What do we know about bleeding risk & antithrombotic management after tricuspid valve interventions?

40

What are the key specific considerations for TAVI in women?

41

SAVR or TAVR: what is best for female patients?

42

Predictors and clinical relevance of residual tricuspid regurgitation after transcatheter repair

43

Nurses and Allied Professionals: How to safely discharge your patient post TAVI?

44

How to manage the complexity of multivalve disease?

45

How to manage conduction disturbances after tricuspid valve interventions?

46

How can multi modality imaging contribute to the assessment of multivalve disease?

47

Nurses and Allied Professionals: How does frailty and cognition impact patient selection for TAVI?

48

Early detection and treatment of aortic stenosis